In the past 40 years,Chinese pediatric cardiac ultrasound technology has made significant progresses from its initial exploration to becoming the core diagnostic tool in pediatric cardiology.The development of pediatric echocardiography in China,including iteration of equipment and technology,clinical application expansion and grassroots promotion standards were reviewed in this article.

Over the past 40 years,prenatal ultrasound in China has undergone a transformative evolution,from basic grayscale imaging to the integration of artificial intelligence(AI).Initial efforts focused on identifying major fetal anomalies and establishing standardized screening systems.In subsequent decades,advances such as 3D/4D imaging,quantitative diagnostic models and multimodal approaches enhanced the accuracy and scope of assessments.Recently,the emergence of AI-driven diagnostics,early trimester screening and multi-omics integration have ushered Chinese prenatal ultrasound into an era of precision and intelligence.Chinese scholars have not only adopted global innovations,but also contributed original,locally adapted solutions and multidisciplinary frameworks.Looking ahead,future development will emphasize intelligent assistance,equitable access,evidence-based systems,and cross-disciplinary integration-driving continued improvement in birth defect prevention and maternal-fetal health.

Cystic renal mass(CRM)is common in clinic,covering a variety of diseases,and the differentiation of benign and malignant CRM is crucial for treatment decisions.Imaging technologies had their own advantages for diagnosis of CRM,while new grading systems and diagnostic methods kept emerged.The definition of CRM,the application and diagnostic progresses of imaging,especially ultrasound for CRM,and the characteristics and shortcomings of existing diagnostic methods were reviewed in this article,aiming to provide reference for accurate diagnosis and treatment of CRM.

Quality control of pediatric musculoskeletal ultrasound(MSKUS)must be integrated throughout the entire diagnostic process.Its core lies in a thorough understanding of the growth,development,and pathophysiological characteristics of the pediatric musculoskeletal system,mastery of MSKUS examination techniques,and the establishment of a systematic and comprehensive diagnostic framework.This review focuses on the core aspects of pre-examination,during examination,and post-examination to describe the quality control points and strategies for pediatric MSKUS.

PET of molecular imaging plays a pivotal role in Alzheimer's disease(AD)by visualizing and quantifying amyloid β(Aβ)deposition,phosphorylated tau protein(T)and glucose metabolism,having important value in the entire process of diagnosis and treatment of AD.The applications of PET multimodal imaging in AD were systematically reviewed in this article,in order to advance precision diagnosis,treatment and scientific management of AD.

Myocardial fibrosis(MF)represents a core pathological basis for cardiovascular disease progression,strongly associated with poor prognosis.The clinical evaluation techniques were invasive,lacking specificity and unable to diagnose early MF.Targeted on activated fibroblasts,radionuclide imaging emerged as a transformative solution,leveraging molecular-level specificity for noninvasive early diagnosis,dynamicly monitoring disease progression and evaluation on treatment response of MF.The scientific foundation,evidences of early diagnostic efficacy,and potential of fibroblast-targeted radionuclide imaging applicated in cardiovascular diseases,as well as its role in risk stratification,prognostic assessment and therapeutic decision support of MF were systematically reviewed in this article.

In the era of precision medicine,integrating radionuclide-based molecular imaging with targeted internal radiotherapy,integrated theranostics of nuclear medicine emerged as a promising and rapidly advancing field to achieve both visualization and precise treatment of tumors.The advances of commonly used and emerging radiotheranostic agents in oncology were systematically reviewed in this article.

Pediatric nuclear medicine achieve precise functional and metabolic assessments with renal dynamic imaging,bone scintigraphy and 18F-FDG PET/CT,playing irreplaceable role for diagnosis and treatment of pediatric diseases.The emergence of novel molecular imaging probes,such as 68 Ga-DOT AT ATE,18F-DOPA and 18F-MFBG,expand clinical application field of pediatric nuclear medicine,while radionuclide therapy using 131I,131I-MIBG and 177 Lu-DOT AT ATE offer targeted options for pediatric thyroid cancer and neuroendocrine tumors.The current status,challenges and future prospect of pediatric nuclear medicine were reviewed in this article.

Nuclear medicine plays a pivotal role in diagnosis and treatment of tumors.The development of radionuclide probes with high affinity and specificity is an effective approach to achieve precise diagnosis and treatment of tumors.With high binding affinity,rapid tissue penetration and excellent pharmacokinetic properties,bicyclic peptide-based radionuclide probes demonstrate remarkable advantages in diagnosis and targeted therapy of tumors.The structural characteristics and design strategies of bicyclic peptide-based radionuclide probes were reviewed in this article,mainly focused on research progresses in targeting tumor-associated receptors.

Liver cancer is one of the leading causes of cancer-related mortality worldwide.The treatment paradigm of HCC is shifting from traditional"single-modality resection"toward an integrated model featuring"multi-strategy synergy".In recent years,neoadjuvant therapies,particularly those combining interventional approaches with immunotherapy before surgery had attracted much attention.The current evidences and emerging trends of interventional and immune-driven strategies in neoadjuvant therapy for liver cancer were reviewed in this article.